https://www.selleckchem.com/pr....oducts/upadacitinib.
297, 95% (8.17-273.76) p 0.001, bradycardia OR = 15.997 95% (4.18-61.18) p 0.001, low variability OR = 10.224, 95% (2.71-38.45) p 0.001, higher baseline of the fetal heart rate calculated for each increment of 1 BPM OR = 1.0547, 95% (1.001-1.116) p = 0.047. Rupture of a previous uterine cesarean scar and placental abruption were characteristic of the HIE-TH group 14.8% vs. 1% p 0.05; and 16.7% vs. 6% p 0.05, respectively. Adverse neonatal outcomes also differed significantly HIE-TH had a higher rate of neon
Like
Comment
Share
